Cite
HARVARD Citation
Uda, H. et al. (n.d.). SAT0203 Significance of extension of tocilizumab infusion intervals from 4 weeks to 6 weeks in ra patients who had shown good response to 4 week intervals. Annals of the rheumatic diseases. p. 849. [Online].